Copyright
©The Author(s) 2022.
World J Clin Cases. Jun 6, 2022; 10(16): 5266-5274
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5266
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5266
Table 1 Baseline clinical features
Features | Cases (n = 61) |
Age (yr) | 74 (64-79) |
Male, n (%) | 45 (73.8) |
BMI (kg/m2) | 25.0 ± 3.4 |
Diabetes mellitus, n (%) | 30 (49.2) |
Hypertension, n (%) | 40 (65.6) |
Dyslipidemia, n (%) | 8 (13.1) |
Current smoking, n (%) | 20 (32.8) |
Previous MI, n (%) | 20 (32.8) |
Previous PCI, n (%) | 9 (14.8) |
Previous CABG, n (%) | 11 (18.0) |
Previous stroke, n (%) | 16 (26.2) |
COPD, n (%) | 3 (4.9) |
CRF, n (%) | 30 (49.2) |
Peripheral vascular disease, n (%) | 3 (4.9) |
LVEF | 42 (32-49) |
LVEF ≤ 35%, n (%) | 20 (32.8) |
Clinical presentation STEMI, n (%) | 18 (29.5) |
NSTEMI, n (%) | 11 (18.0) |
UA, n (%) | 32 (52.5) |
1SYNTAX score | 43.2 ± 10.0 |
EuroSCORE | 12 (10-15) |
GRACE score | 163 (145-195) |
- Citation: Huang YX, Xu ZM, Zhao L, Cao Y, Chen Y, Qiu YG, Liu YM, Zhang PY, He JC, Li TC. Long-term outcomes of high-risk percutaneous coronary interventions under extracorporeal membrane oxygenation support: An observational study. World J Clin Cases 2022; 10(16): 5266-5274
- URL: https://www.wjgnet.com/2307-8960/full/v10/i16/5266.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i16.5266